These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
130 related items for PubMed ID: 2767556
1. Effect of T-activin on the course of experimental infection with Taenia crassiceps (Zeder, 1800) in mice. Hermánek J, Prokopic J. Folia Parasitol (Praha); 1989; 36(2):117-26. PubMed ID: 2767556 [Abstract] [Full Text] [Related]
2. Influence of thymic preparations on the result of experimental infection with Taenia crassiceps (Zeder, 1800) in ICR mice. Hermánek J, Prokopic J. Folia Parasitol (Praha); 1989; 36(4):331-40. PubMed ID: 2488049 [Abstract] [Full Text] [Related]
3. Nonspecific immunomodulation influences resistance of mice to experimental infection with Mesocestoides corti and Ascaris suum. Hermánek J. J Helminthol; 1991 Jun; 65(2):121-32. PubMed ID: 1880386 [Abstract] [Full Text] [Related]
4. A mouse air pouch model for evaluating the immune response to Taenia crassiceps infection. Gaspar EB, Sakai YI, Gaspari ED. Exp Parasitol; 2014 Feb; 137():66-73. PubMed ID: 24378477 [Abstract] [Full Text] [Related]
5. Effect of oral zinc supplementation upon Taenia crassiceps murine cysticercosis. Fragoso G, Lastra MD, Aguilar AE, Pastelin R, Rosas G, Meneses G, Sciutto E, Lamoyi E. J Parasitol; 2001 Oct; 87(5):1034-9. PubMed ID: 11695361 [Abstract] [Full Text] [Related]
6. [Effects of T-activin in viral myocarditis in animal experiments]. Kipshidze NN, Dzhaparidze MM, Bulusashvili RV, Khuchua AV, Zbiadadze NA. Biull Eksp Biol Med; 1988 Jun; 105(6):705-7. PubMed ID: 3260519 [Abstract] [Full Text] [Related]
7. Clinical and immunologic effects of T-activin therapy in early stage melanoma patients. Stanojević-Bakić N, Milosević D, Vucković-Dekić L, Sasić M, Marković L. Neoplasma; 1996 Jun; 43(4):245-52. PubMed ID: 8931749 [Abstract] [Full Text] [Related]
8. [Effects of T-activin on the morphology of the thymus gland in experimental injury of the lower limbs in mice (anti-stress effect of T-activin)]. Koval'skaia NI, Arion VN, Blinkov VN. Biull Eksp Biol Med; 1990 Jun; 109(6):585-7. PubMed ID: 2397300 [Abstract] [Full Text] [Related]
9. Changes in ascorbic acid content in various organs and serum of mice experimentally infected with Taenia crassiceps (Zeder, 1800) cysticerci. Strnadová E, Prokopic J. Folia Parasitol (Praha); 1985 Jun; 32(2):185-8. PubMed ID: 4007703 [Abstract] [Full Text] [Related]
10. Immunization against Taenia crassiceps cysticercosis: identification of the most promising antigens in the induction of protective immunity. Valdez F, Hernández M, Govezensky T, Fragoso G, Sciutto E. J Parasitol; 1994 Dec; 80(6):931-6. PubMed ID: 7799166 [Abstract] [Full Text] [Related]
11. The effect of using T-activin in the therapy of the newborn with suppurative surgical infection. Samsygin SA, Dolgina EN, Arion VYa, Romanova LA, Shchevochkina GI, Ovchinnikova EA. J Hyg Epidemiol Microbiol Immunol; 1989 Dec; 33(3):269-76. PubMed ID: 2809182 [Abstract] [Full Text] [Related]
13. Dependency of resistance of mice immunized against Taenia crassiceps on the dose of soluble antigen. Lukes S. Folia Parasitol (Praha); 1987 Dec; 34(4):329-33. PubMed ID: 3428764 [Abstract] [Full Text] [Related]
14. Taenia crassiceps: in vivo and in vitro models. Willms K, Zurabian R. Parasitology; 2010 Mar; 137(3):335-46. PubMed ID: 19835660 [Abstract] [Full Text] [Related]
15. Kinetics and characterization of cellular responses in the peritoneal cavity of mice infected with Taenia crassiceps. Padilla A, Govezensky T, Sciutto E, Jimenez-García LF, Gonsebatt ME, Ramirez P, Larralde C. J Parasitol; 2001 Jun; 87(3):591-9. PubMed ID: 11426723 [Abstract] [Full Text] [Related]
16. [The use of T-activin in the intensive therapy of the postoperative period in gestosis patients]. Ianiushina VV. Anesteziol Reanimatol; 1992 Jun; (4):42-5. PubMed ID: 1485674 [Abstract] [Full Text] [Related]
17. Evaluation of Taenia solium and Taenia crassiceps cysticercal antigens for the serodiagnosis of neurocysticercosis. Arruda GC, da Silva AD, Quagliato EM, Maretti MA, Rossi CL. Trop Med Int Health; 2005 Oct; 10(10):1005-12. PubMed ID: 16185235 [Abstract] [Full Text] [Related]
18. [Principles of immunocorrective therapy using the thymus preparation T-activin]. Arion VIa, Ivanushkin EF. Khirurgiia (Mosk); 1984 Nov; (11):44-8. PubMed ID: 6335205 [No Abstract] [Full Text] [Related]
19. Taenia crassiceps cysticercosis: humoral immune response and protection elicited by DNA immunization. Rosas G, Cruz-Revilla C, Fragoso G, López-Casillas F, Pérez A, Bonilla MA, Rosales R, Sciutto E. J Parasitol; 1998 Jun; 84(3):516-23. PubMed ID: 9645849 [Abstract] [Full Text] [Related]
20. Adjuvant effect of Taenia crassiceps glycans against leishmanial antigens in mice infected with Leishmania mexicana. Dissanayake S, Shahin A, Ameen AM. Mol Immunol; 2005 Aug; 42(12):1495-502. PubMed ID: 15950742 [Abstract] [Full Text] [Related] Page: [Next] [New Search]